Albert David
805.15
-4.75(-0.59%)
Market Cap₹462.20 Cr
PE Ratio74.11
IndustryHealthcare
Company Performance:
1D-0.59%
1M-13.73%
6M-9.42%
1Y-33.93%
5Y+63.76%
View Company Insightsright
Latest news about Albert David
Albert David Limited Reports Mixed Q1 FY2026 Results with Decline in Revenue and Profit Aug 04, 2025
Albert David, a pharmaceutical company, released Q1 FY2026 results showing a 21% year-on-year revenue decline to Rs. 7,056.64 lakhs. Net profit fell 58% to Rs. 793.76 lakhs. EPS decreased to Rs. 13.91 from Rs. 33.02 in Q1 FY2025. The company's equity share capital remained unchanged at Rs. 570.72 lakhs. The results were approved by the board on August 2, 2025, after a limited review by statutory auditors.
Albert David Limited Appoints Pharma Veteran as New Independent Director, Approves Q1 Results Aug 02, 2025
Albert David Reports 59% Decline in Q1 Net Profit, Appoints New Independent Director Aug 02, 2025
Albert David Ltd Reports Q4 FY23 Results: EBITDA Loss Widens, Revenue Declines; Recommends Dividend May 13, 2025